NEW YORK (Reuters Health) – Appropriate use of intravenous narcotics is safe and perhaps even beneficial in patients with acute coronary syndromes, according to Israeli researchers. In general,…
NEW YORK (Reuters Health) – High-potency, stereotactic body radiation therapy (SBRT) may improve survival for patients with medically inoperable early stage lung cancer, results of a multicenter phase…
NEW YORK (Reuters Health) – Urine dipsticks are unreliable and cost-ineffective at screening children for chronic kidney disease, investigators report in the April issue of Pediatrics. In 2007,…
NEW YORK (Reuters Health) – Excisional biopsies are best for diagnosing cutaneous melanoma, because partial biopsies have higher risks of misdiagnosis, adverse events, and microstaging inaccuracy, Australian researchers…
NEW YORK (Reuters Health) – Patients with the H1N1 virus who started oseltamivir in the first 3 days of illness had shorter periods of viral shedding, according to…
NEW YORK (Reuters Health) – As first-line treatment for progressive chronic lymphocytic leukemia (CLL), cladribine and fludarabine are equally effective and safe in combination with cyclophosphamide, according to…
NEW YORK (Reuters Health) – With small breast cancers, doing complete axillary dissections only for positive sentinel lymph node biopsies (SNLB) yields the same 10-year survival – roughly…
NEW YORK (Reuters Health) – Injection of Macroplastique (Uroplasty), a urethral bulking agent, can improve female stress urinary incontinence for at least two years, new research shows. Exactly…
NEW YORK (Reuters Health) – There’s no good evidence that maintenance therapy improves the outcome of small-cell lung cancer (SCLC), according to a meta-analysis published February 25th in…
NEW YORK (Reuters Health) – A treatment called DRIFT (Drainage, Irrigation, and Fibrinolytic Therapy) may improve developmental outcomes and survival in preterm infants with posthemorrhagic cerebral ventricular dilatation,…
